(Taken from the application): Previous studies from the Principal Investigator's laboratory support the hypothesis that IgM-RF- bearing immune complexes are involved in initiating or perpetuating the chronic inflammatory state in juvenile rheumatoid arthritis (JRA). In addition to activating complement, with the formation of phlogistic C3a and C5a molecules, immune complexes isolated from JRA synovial fluid have been shown to induce the secretion of interleukin 1beta (IL-1beta) from monocytic U937 cells. Furthermore, model BSA-anti-BSA immune complexes induce other cytokines in addition to IL-1B, from human peripheral blood mononuclear cells (PBMC's), including two believed to be involved in the pathophysiology of rheumatoid disease: GM-CSF and IL-8. Preliminary data from the P.I.'s laboratory also suggest that the ability of immune complexes to induce leukocyte cytokine expression may be dependent upon their size and composition. This proposal will test that hypothesis and examine in further detail the cellular mechanisms responsible for the induction of cytokines by JRA serum and synovial fluid immune complexes. In the first set of experiments, immune complexes purified from JRA serum and synovial fluids will be characterized in detail (Specific Aim 1). Specifically, Western blotting to identify immunoglobulin and complement content, quantitative ELISA assays for bound complement components, and qualitative ELISA assays for the presence of IgA, IgM, and IgG-rheumatoid factors (RF's) within the complexes will be undertaken. The effects of IgM-RF on complement binding to the immune complexes will also be examined. In the next set of experiments (Specific Aim 2), JRA immune complexes will be incubated with PBMC's to determine whether these complexes or some subset of them can induce 4 cytokines believed to be critical in the pathophysiology of synovial inflammation: IL-1 beta, IL-6, IL-8, and GM-CSF. Cellular/molecular mechanisms involved in cytokine expression in these experiments will also be examined. Finally, the roles of immune complex size and composition in determining their pathologic potential will be examined in an in vitro model (Specific Aim 3). In these experiments, model immune complexes of specific size and composition will be constructed in the laboratory. The capacity of these complexes to induce IL-1 beta from monocytic U937 cells and the cellular signalling mechanisms associated with that expression (specifically, tyrosine kinase activation and intracellular calcium release), will then be examined in detail.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR043967-01
Application #
2083712
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1995-09-30
Project End
1998-08-31
Budget Start
1995-09-30
Budget End
1996-08-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Wayne State University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Jiang, Kaiyu; Chen, Yanmin; Jarvis, James N (2004) Cord blood and adult T cells show different responses to C1q-bearing immune complexes. Cell Immunol 229:62-7
Jiang, K; Chen, Y; Xu, C-S et al. (2003) T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis. Clin Exp Immunol 131:61-7
Xiao, S; Xu, C; Jarvis, J N (2001) C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immu Clin Exp Immunol 125:360-7
Jarvis, J N; Xu, C; Wang, W et al. (1999) Immune complex size and complement regulate cytokine production by peripheral blood mononuclear cells. Clin Immunol 93:274-82
Amit, A; Kindzelskii, A L; Zanoni, J et al. (1999) Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils. Cell Immunol 194:47-53
Jarvis, J N (1998) Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases. Curr Opin Rheumatol 10:459-67
Jarvis, J N; Zhao, L; Xu, C S et al. (1997) Constitutive expression c-fos, c-jun, and NF kappa B mRNA is in nucleated fetal blood cells and up-regulation of c-fos and c-jun with anti-CD3 stimulation. Biol Neonate 72:329-36
Jarvis, J N; Wang, W; Moore, H T et al. (1997) In vitro induction of proinflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes. Arthritis Rheum 40:2039-46
Schwartz, M M; Simpson, P; Kerr, K L et al. (1997) Juvenile rheumatoid arthritis in African Americans. J Rheumatol 24:1826-9
Jarvis, J N; Zhao, L; Moore, H T et al. (1996) Regulation of cytokine mRNA expression in activated lymphocytes by human choriocarcinoma JAR cells. Cell Immunol 168:251-7